Joe Neguse (D-CO)
To establish a Biotechnology Management Office in the Department of Defense and to provide support for the research and development of bioindustrial manufacturing processes, and for other purposes.
A Democratic bill with no cosponsors
Last activity — Referred to the House Committee on Armed Services.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill aims to create a Biotechnology Management Office within the Department of Defense. The Secretary of Defense is required to appoint a senior official with biotechnology experience to lead this new office. The office will work under the direction of the Deputy Secretary of Defense to develop, acquire, and maintain biotechnology capabilities. Responsibilities include creating research roadmaps, updating policies, and coordinating with various partners and industries. Additionally, the bill provides support for the research and development of bioindustrial manufacturing processes.
Yes· 3 of 10
- Scored +5
Does this put more money into scientific research?
The bill explicitly provides for the use of funds for research, development, and evaluation of biotechnology and bioindustrial processes.
- Scored +4
Does this put more money into medical research?
The bill authorizes the use of funds for research, development, test, and evaluation of bioindustrial manufacturing processes.
- Scored +3
Is this likely to create jobs?
The bill fosters innovation ecosystems and public-private partnerships which can stimulate job growth in the biotechnology sector.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Development of Biotechnology Capabilities: The establishment of the Biotechnology Management Office is intended to foster the development, acquisition, and sustainment of broad-based biotechnology capabilities for the Department (Section 1, subsection b).
-
Streamlined Processes: The office is responsible for proposing ways to streamline the regulatory or acquisition processes within the Department (Section 1, subsection c, paragraph 4).
-
Economic and Innovation Growth: The office will support the development of public-private partnerships with academia, industry, and other State and local government partners, which includes fostering regionally focused innovation ecosystems (Section 1, subsection c, paragraph 6).
-
Workforce Identification: The office is tasked with identifying gaps in the biotechnology workforce and training across the Department (Section 1, subsection c, paragraph 7).
-
Manufacturing Support: The bill amends existing law to allow funds to be used for research, development, test, and evaluation, including design and construction activities related to bioindustrial manufacturing processes (Section 2).
Potential Negative Impacts for People
- Limited Lifespan of the Office: The Biotechnology Management Office is subject to a sunset provision, meaning the section establishing it shall terminate on September 30, 2030 (Section 1, subsection d).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Economy And Finance
- Is this likely to create jobs? — The bill fosters innovation ecosystems and public-private partnerships which can stimulate job growth in the biotechnology sector. Does this make it easier to run a small business? — The creation of regionally focused innovation ecosystems and public-private partnerships can provide new opportunities for smaller industry partners.
- Education And Technology
- Does this put more money into scientific research? — The bill explicitly provides for the use of funds for research, development, and evaluation of biotechnology and bioindustrial processes.
- Demographic And Interest Groups
- Would business owners be better off under this? — The emphasis on public-private partnerships and innovation ecosystems benefits industry leaders and business owners in the biotech sector. Would people in cities be better off under this? — The development of regional innovation ecosystems may benefit urban centers where biotechnology industry clusters are often located.
- Healthcare
- Does this put more money into medical research? — The bill authorizes the use of funds for research, development, test, and evaluation of bioindustrial manufacturing processes.
- National Security And Foreign Policy
- Does this strengthen ties with allied countries? — The bill directs the new office to coordinate with international partners regarding biotechnology. Does this better protect the country from computer attacks? — Developing biotechnology capabilities can enhance the broader technological security of the Department of Defense.
- Environment Energy And Infrastructure
- Does this put more money into wind, solar and other renewable power? — The support for bioindustrial manufacturing processes may advance biological approaches to sustainable production.
- Governance And Ideology
- Does this make what the government does easier for the public to see? — The bill requires the Secretary of Defense to brief congressional defense committees on the scope and implementation of the new office.
- 12/11/2025
- Referred to the House Committee on Armed Services.
- Introduced in House
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.